Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
6.66
+0.16 (2.46%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $3.87 million as of October 29, 2024. Its market cap has increased by 13.78% in one year.
Market Cap
3.87M
Enterprise Value
-2.12M
1-Year Change
13.78%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since December 7, 2015, Biodexa Pharmaceuticals's market cap has decreased from $492.00M to $3.87M, a decrease of -99.21%. That is a compound annual growth rate of -41.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 2.40M | 26.32% |
| Dec 29, 2023 | 1.90M | -51.28% |
| Dec 30, 2022 | 3.90M | -70.45% |
| Dec 31, 2021 | 13.20M | 29.41% |
| Dec 31, 2020 | 10.20M | 21.43% |
| Dec 31, 2019 | 8.40M | -55.56% |
| Dec 31, 2018 | 18.90M | -76.84% |
| Dec 29, 2017 | 81.60M | -55.82% |
| Dec 30, 2016 | 184.70M | -43.10% |
| Dec 31, 2015 | 324.60M | -34.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonnet BioTherapeutics Holdings | 3.91M |
| Pasithea Therapeutics | 3.87M |
| Chromocell Therapeutics | 3.86M |
| Genetic Technologies | 3.78M |
| Artelo Biosciences | 3.78M |
| Fresh2 Group | 3.65M |
| Bone Biologics | 3.63M |
| Lixte Biotechnology Holdings | 3.60M |